Format

Send to

Choose Destination
J Viral Hepat. 2015 Oct;22(10):784-91. doi: 10.1111/jvh.12392. Epub 2015 Jan 21.

Hepatitis C virus infection: a risk factor for Parkinson's disease.

Author information

1
Graduate Institute of Epidemiology and Preventive medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
2
Department of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan.
3
School of Oral Hygiene, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan.
4
Department and Graduate Institute of Health Care Management, Chang Gung University, Tao-Yuan, Taiwan.
5
Department of Health Industry Management, School of Health Care Management, Kainan University, Taoyuan, Taiwan.
6
Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
7
Department of Neurology and Pharmacology, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan.

Abstract

Recent studies found that hepatitis C virus (HCV) may invade the central nervous system, and both HCV and Parkinson's disease (PD) have in common the overexpression of inflammatory biomarkers. We analysed data from a community-based integrated screening programme based on a total of 62,276 subjects. We used logistic regression models to investigate association between HCV infection and PD. The neurotoxicity of HCV was evaluated in the midbrain neuron-glia coculture system in rats. The cytokine/chemokine array was performed to measure the differences of amounts of cytokines released from midbrain in the presence and absence of HCV. The crude odds ratios (ORs) for having PD were 0.62 [95% confidence interval (CI), 0.48-0.81] and 1.91 (95% CI, 1.48-2.47) for hepatitis B virus (HBV) and HCV. After controlling for potential confounders, the association between HCV and PD remained statistically significant (adjusted OR = 1.39; 95% CI, 1.07-1.80), but not significantly different between HBV and PD. The HCV induced 60% dopaminergic neuron death in the midbrain neuron-glia coculture system in rats, similar to that of 1-methyl-4-phenylpyridinium (MPP(+) ) but not caused by HBV. This link was further supported by the finding that HCV infection may release the inflammatory cytokines, which may play a role in the pathogenesis of PD. In conclusion, our study demonstrated a significantly positive epidemiological association between HCV infection and PD and corroborated the dopaminergic toxicity of HCV similar to that of MPP(+) .

KEYWORDS:

Parkinson's disease; community; hepatitis C; neurotoxicity; risk factor

PMID:
25608223
DOI:
10.1111/jvh.12392
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center